{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Drugs 2017, Part 1

Purpose of Activity

To provide information about six new drugs recently approved by the FDA.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify indications for these new drugs.
  2. List major adverse reactions associated with these drugs.
  3. Discuss nursing considerations for these drugs.
Price: $17.95

Credits:

  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: N0217A
Published: Feb 2017
Expires: 12/4/2020
Sources: Nursing2019
Passing Score: 13/18 (72%)
Authors: Daniel A. Hussar, PhD